OrbiMed’s Lifestance Health LFST Stock Holding History

OrbiMed’s Portfolio LFST Stock Details LFST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.1M	Buy	947,400 +447,400	+89%	+$3.46M	0.19%	84
2026 Q1	$3.19M	Buy	+500,000	New	+$3.48M	0.06%	103

Other funds holding LFST

TGA

TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Summit Partners Boston, Massachusetts $609M AUM 7.66% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

OrbiMed's LFST Position: Q2 2026 in Review

OrbiMed increased its Lifestance Health (LFST) stake by 89% in Q2 2026, buying an estimated $3.46M and bringing the position to 947,400 shares worth $10.1M. The position accounts for 0.19% of the portfolio, ranked #84.

OrbiMed first reported a position in LFST in Q1 2026 and has held it in 2 quarters since. 287 funds tracked by Wall St. Rank hold LFST as of Q2 2026.

OrbiMed held 947,400 shares of Lifestance Health worth $10.1M as of Q2 2026.
OrbiMed bought 447,400 Lifestance Health shares in Q2 2026, an estimated $3.46M.
Lifestance Health made up 0.19% of OrbiMed's portfolio in Q2 2026, its #84 holding.
OrbiMed first reported a position in Lifestance Health in Q1 2026 and has held it in 2 quarters since.
287 funds tracked by Wall St. Rank held Lifestance Health as of Q2 2026.

Based on OrbiMed's 13F filing for Q2 2026, filed 14 Aug 2026.